SNGX

SNGX

USD

Soligenix Inc. Common Stock

$1.340-0.100 (-6.944%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.440

Hoch

$1.470

Tief

$1.300

Volumen

0.24M

Unternehmensfundamentaldaten

Marktkapitalisierung

11.2M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

4.32M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $1.09Aktuell $1.340Hoch $6.23

Ähnliche Nachrichten

PR Newswire

Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products...

Mehr anzeigen
Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma
PR Newswire

Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products...

Mehr anzeigen
Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma
PR Newswire

Soligenix Announces Closing of $7.5 Million Public Offering

Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing...

Mehr anzeigen
Soligenix Announces Closing of $7.5 Million Public Offering
PR Newswire

Soligenix Announces Pricing of $7.5 Million Public Offering

Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing...

Mehr anzeigen
Soligenix Announces Pricing of $7.5 Million Public Offering